UK Medical Devices Market Worth $17.5 Billion by 2020, Says A New Research Report at MarketOptimizer.org
BBC Capaldi’s casting is, Who showrunner Steven Moffat tells us, “a big declaration of intent” for the long-running sci-fi series – a “statement of [its] importance” – but how much do we actually know about the new Doctor and his upcoming adventures? Both Moffat and Capaldi’s co-star Jenna Coleman agree that the 55-year-old actor will be ” so different ” to his 31-year-old predecessor Matt Smith, with the show’s head writer promising an “old beast” with a “snarl”. “We’ve got used to two brilliant iterations of the younger, more puppy-dog Doctor and [David Tennant and Matt] have both been superlative,” Moffat said in November . “But now it’s time for the old beast to snarl at you for a bit! “Sometimes you see that a bit in Matt Smith’s Doctor – he will remind the people around him, ‘I’m not really like this’ – but I think Peter’s Doctor will make that even clearer.” BBC Guiding the Doctor through his latest traumatic regeneration, and fans through the transition from “puppy dog” Smith to “old beast” Capaldi, will be the Paternoster Gang – Vastra (Neve McIntosh), Jenny (Catrin Stewart) and Strax (Dan Starkey) – as Moffat first revealed to Digital Spy back in July . “Vastra, Jenny and Strax are all enormously popular characters, and we’ve got Clara still continuing,” he explained at last year’s San Diego Comic-Con. “[That] allows us to do [the regeneration] in a very different way from the way that we did it in ‘The Eleventh Hour’.” “You can push that [new] Doctor a bit further, maybe, if you’ve got a familiar world around him.” So that’s the Doctor – but what of his adventures? Series eight of Doctor Who will air as an uninterrupted run, with Moffat and Brian Minchin as executive producers. Stepping in to replace producer Marcus Wilson – who departed the show following Matt Smith’s swansong ‘ The Time of the Doctor ‘ – are Nikki Wilson and Peter Bennett. The latter produced Smith’s first series in 2010 and also worked on Torchwood, while the former is a veteran of both Who and The Sarah Jane Adventures. BBC Believed to be joining Moffat on this year’s writing team are Phil Ford, Mark Gatiss, Neil Cross and Gareth Roberts – with Jack Lothian (Shameless, Sinbad) developing a script and Neil Gaiman also keen for another go-round . On the directing front, The Kill List and Sightseers filmmaker Ben Wheatley is helming the first two 2014 episodes – quite a coup for Who – followed by Paul Murphy on episodes three and six. Douglas Mackinnon is also confirmed for an unspecified block, but the smart money’s on episodes four and five. With his new team in place, Steven Moffat is promising an escape from the uber-slick Doctor Who we’ve seen of late – from August, expect something a little more “raw”.
The medical devices market size was approximately $12 billion in 2012 and is expected to reach approximately $17.5 billion by 2020 with a projected CAGR of 4.8%. Complete report is available at http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-uk.html . The positive trends in the UK healthcare market can be attributed primarily to: AAAaA Increasing elderly population AAAaA Universal healthcare insurance AAAaA High degree of access to healthcare facilities Scope The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes – AAAaA Overview of the pharmaceutical and medical devices market of the UK including the market size, market segmentation, key drivers and barriers. AAAaA Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Novartis, Sanofi and AstraZeneca. The key players covered for the medical devices market are Medtronic, Siemens Healthcare, Essilor Internaltional, Hoffmann-La Roche, and Coloplast. AAAaA Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices. AAAaA A detailed analysis of the political and economic environment of the UK including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure. AAAaA An overview of the opportunities and challenges for growth that exist in the healthcare market of the UK Reasons to buy The report on the UK comprehensively covers both the pharmaceutical and the medical devices markets of the UK. The report will enhance your decision making capability. It will allow you to – AAAaA Develop business strategies by understanding the trends shaping and driving the healthcare market of the UK. AAAaA Drive revenue by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the the UK healthcare market in the future.